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Abstract 
The factors leading to persistent infection of foot-and-mouth disease (FMD) virus in ruminants are not well defined. 
This paper provides evidence of the presence of interleukin-10 (IL-10) early in the course of infection (1–4 days) as 
a factor in the development of persistence of FMD virus in cattle. Results showed that serum IL-10 in carrier cattle 
infected with FMD virus type O (n = 4) was detected and peaked at 1 or 2 days post infection and rapidly declined 
thereafter. In contract, serum IL-10 levels in non-carrier cattle (n = 21) were very low or undetectable during the same 
period.
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Introduction, methods and results
Foot-and-mouth disease (FMD) virus is a small, non-
enveloped single stranded, positive sense RNA virus 
(Picornaviridae family) and has seven serotypes: O, A, C, 
Asia 1, and Southern African Territories (SAT) 1, 2 and 
3, all of which cause a highly contagious vesicular dis-
ease in cloven-hoofed animals [1]. After the acute phase 
of infection, which may be associated with clinical dis-
ease or with asymptomatic infection, up to 50% of FMD 
virus-infected cattle and other bovids may carry the virus 
in their pharyngeal regions for months or years without 
showing any clinical signs of disease, and may be criti-
cal to the epidemiology of FMD, at least at the wildlife 
domestic cattle interface (reviewed in [1, 2]). Carrier ani-
mals are defined as persistently infected animals from 
which FMD virus can be recovered from esophageal-
pharyngeal fluid (Probang) for more than 28  days after 
infection [3]. FMD virus is eventually eliminated from 
carriers. However, the host factors that enable persis-
tence or elimination are not known. Previous studies 
showed that the persistence with FMD virus was less 
likely to be established if the immune response to vac-
cination had developed sufficiently [4] and the rate of 
clearance of FMD virus from the pharyngeal region may 
be related to the likelihood of persistence [5, 6]. Recent 
studies have shown that FMD virus-induced immuno-
suppression during the acute stage of infection is not 
due to infection of the lymphocytes [7] but lack of T cell 
responsiveness via interleukin-10 (IL-10) signalling [8]. 
IL-10 is an immunoregulatory cytokine that can modu-
late immune processes associated with the anti-inflam-
matory response and the inhibition of cellular responses 
via a variety of mechanisms. It has been demonstrated 
that elevated levels of IL-10 production are associated 
with persistent infection with hepatitis C virus (HCV) 
[9, 10], HIV [11–13], Epstein–Barr virus [14] and lym-
phocytic choriomeningitis virus (LCMV) [15, 16]. Inter-
ferons (IFN) are known to have antiviral activity and 
are considered to be important in the initial host cell 
defence against virus infection. It has been demonstrated 
that replication of FMD virus is highly sensitive to type 
I and II IFNs and that porcine or bovine IFN added to 
supernatants of cell cultures inhibits FMD virus replica-
tion in vitro [17, 18] and clears FMD virus from persis-
tently-infected cells [18]. The aim of the current study 
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was to define the early IL-10 and IFN responses of cattle 
infected with the type O FMD virus and its relationship 
to the persistence of FMD virus.
To address this, serum samples collected at 0, 1, 2, 3, 
and 4 days post-infection (dpi) from 15 cattle of vary-
ing ages infected with the type O UKG/34/2001 virus 
and similarly from ten cattle infected with the type 
O SKR/1/2000 virus were used for detection of IL-10 
and IFN protein. Detailed results regarding the clini-
cal profiles are presented elsewhere [5, 6]. Briefly, all 
inoculated animals showed clinical signs of FMD with 
the development of fever and vesicles on all feet, and 
tongue. Viraemia peaked at 2–3 dpi, which was cleared 
by day 4 in all animals. All cattle had specific virus in 
their Probang samples for at least 7  days after virus 
exposure which was cleared from the pharynx at differ-
ent rates. Four out of 25 cattle became carrier animals 
as evidenced by virus in their Probang samples after 28 
dpi and later. The remaining 21 cattle did not develop 
the carrier state (Table 1). Statistical analyses were car-
ried out by using a non-parametric test (independent 
samples t test using Excel). P < 0.05 was considered sta-
tistically significant.
To analyze differences in humoral responses between 
carriers (n = 4) and non-carriers (n = 21), IgG antibod-
ies to the structural proteins of FMD virus were quanti-
fied in sera using liquid phase blocking ELISA (LPBE) 
as described previously [19]. Antibody titre of  <  1:45 is 
considered as negative. As shown in (Table 2), the cohort 
(n  =  15) infected with the type O UKG/34/2001 had 
seroconverted to be FMD positive. Type-specific anti-
bodies were detected in all inoculated animals by 4 dpi 
(Table 2) and in the majority of contact animals (VD36, 
VD37, VD42, VD43, VD46, VD47, VD50) by 6 dpi 
(Table 2). There are no significant difference in levels of 
serum IgG antibodies to the structural proteins of FMD 
virus between carrier cattle and non-carrier animals 
(p = 0.44, p > 0.05). Similar results were also observed in 
sera collected from the cohort infected with the type O 
SKR isolate (data not shown). The results obtained sug-
gest that the IgG antibody response to structural proteins 
of FMD virus is not associated with the development of 
persistence in cattle, which is consistent with previous 
reports [1].
To investigate if elevation of serum IL-10 during the 
acute infection correlates with development of persistent 
Table 1 Cattle infected with foot-and-mouth disease virus were used in this study.
Animal ID Age (days) Route of infection Carrier Status Virus
VD34 273 Subepidermo-lingual Non-carrier FMDV O UKG34/2001
VD35 335 Subepidermo-lingual Non-carrier FMDV O UKG34/2001
VD40 243 Subepidermo-lingual Carrier FMDV O UKG34/2001
VD41 304 Subepidermo-lingual Carrier FMDV O UKG34/2001
VD44 91 Subepidermo-lingual Non-carrier FMDV O UKG34/2001
VD45 91 Subepidermo-lingual Non-carrier FMDV O UKG34/2001
VD48 91 Subepidermo-lingual Non-carrier FMDV O UKG34/2001
VD49 91 Subepidermo-lingual Non-carrier FMDV O UKG34/2001
VD36 335 Direct contact Non-carrier FMDV O UKG34/2001
VD37 243 Direct contact Non-carrier FMDV O UKG34/2001
VD42 243 Direct contact Non-carrier FMDV O UKG34/2001
VD43 213 Direct contact Non-carrier FMDV O UKG34/2001
VD46 91 Direct contact Non-carrier FMDV O UKG34/2001
VD47 91 Direct contact Non-carrier FMDV O UKG34/2001
VD50 91 Direct contact Non-carrier FMDV O UKG34/2001
VI56 274 Subepidermo-lingual Carrier FMDV O SKR 2000
VI57 152 Subepidermo-lingual Non-carrier FMDV O SKR 2000
VI58 274 Subepidermo-lingual Carrier FMDV O SKR 2000
VI59 274 Direct contact Non-carrier FMDV O SKR 2000
VI60 152 Direct contact Non-carrier FMDV O SKR 2000
VI61 152 Subepidermo-lingual Non-carrier FMDV O SKR 2000
VI62 152 Subepidermo-lingual Non-carrier FMDV O SKR 2000
VI63 152 Direct contact Non-carrier FMDV O SKR 2000
VI64 274 Direct contact Non-carrier FMDV O SKR 2000
VI65 274 Direct contact Non-carrier FMDV O SKR 2000
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infection in cattle, IL-10 was measured basically follow-
ing the method of Kwong et  al. [20]. Briefly, enzyme-
linked immunosorbent assay (ELISA) plates were coated 
with anti-IL-10 and each cattle serum was tested in 
duplicate. The assay was repeated three times. As shown 
in Figure 1, the elevation of serum IL-10 during the acute 
phase of FMD virus infection with either type O UKG or 
type O SKR isolates (from 1 to 4 dpi) was only observed 
in sera collected from carrier cattle (n =  4). In the car-
rier group, serum IL-10 was detected and peaked at 1 or 
2 dpi and rapidly declined afterwards. In contrast, it was 
evident that levels of IL-10 in sera from the non-carrier 
group (n = 21) were much lower or undetectable. Com-
parison of serum IL-10 levels between carrier and non-
carrier cattle showed that levels from carrier cattle during 
early infection were significantly higher than in non-car-
rier animals (p = 0.025, p < 0.05), suggesting an associa-
tion of IL-10 response during the acute phase of infection 
with a common outcome of FMD disease (i.e. persis-
tence) in cattle. Age at infection is known to influence the 
establishment of viral persistence [21, 22] and bacterial 
infection [23]. It has also been shown that infected calves 
(4–9 weeks of age) with FMD virus did not always devel-
oped clearly visible clinical signs of FMD [24] as observed 
in infected adult cattle. Interestingly, persistent infection 
was previously reported to only occur in a group of cat-
tle which is older than 8 months at infection [25]. Simi-
lar observation was found in this study. No animal at age 
of younger than 6 months at infection (n = 12) became 
carrier (Table  1), which is correlated with the observa-
tions that no elevation of serum IL-10 during the acute 
phase of FMD virus infection with either type O UKG 
or type O SKR isolates (from 1 to 4 dpi), IL-10 ranging 
from −0.07 ± 0.21 to −0.08 ± 0.12 was observed in sera 
collected from these young animals, further suggesting 
IL-10 as a contributing factor in the likelihood of persis-
tence of FMD virus. In contrast, when the IFN-gamma 
response was tested using the same serum samples, the 
results did not correlate with the outcome of disease (i.e. 
carrier or non-carrier) although increases in levels of 
serum IFN-gamma occurred in some animals after infec-
tion (data not shown).
Discussion
The results obtained in this study suggest that the 
humoral IgG response to structural proteins of FMD 
virus is not associated with the development of persis-
tence in cattle, however, the previous study showed that 
persistence with FMD virus was less likely to be estab-
lished if effective immune response to vaccination had 
developed [4]. IL-10 is an immunoregulatory cytokine 
which is widely acknowledged to contribute to the inhibi-
tion of immune responses via a variety of mechanisms. 
Many studies with other viruses have indicated that 
IL-10 initiates T cell inactivation during viral infection 
and have concluded that this can lead to viral persistence 
[1, 9–16]. The present paper provides evidence of the 
association of IL-10 response during the acute phase of 
infection with a common outcome of FMD disease (i.e. 
persistence) in cattle. Although much is still unclear how 
IL-10 regulates the host immune response, it is possible 
that the relatively high IL-10 response causes a delay in or 
Table 2 Antibody response in cattle infected with foot-and-mouth disease virus.
Animal ID Days post inoculation
0 1 2 3 4 5 6 7 9 15 21 28
VD34 Neg Neg Neg Neg 128 1448 ≥2896 >2048 ≥2896 ≥2896 >2048 >2048
VD35 Neg Neg Neg Neg 362 ≥2896 ≥2896 >2048
VD40 Neg Neg Neg Neg 128 1024 1448 >2048 1448 1448 1448 1448
VD41 Neg Neg Neg Neg 90 1448 1448 >2048 1448 2048 >2048 >2048
VD44 Neg Neg Neg 45 1024 ≥2896 ≥2896 >2048 1448 ≥ 2896 >2048 >2048
VD45 Neg Neg Neg Neg 128 1448 1448 >2048 1448 2048 >2048 >2048
VD48 Neg Neg Neg Neg 128 ≥2896 ≥2896 >2048 ND ND >2048 >2048
VD49 Neg Neg Neg Neg 45 Neg 1024 >2048
VD36 Neg Neg Neg Neg Neg Neg 362 1448
VD37 Neg Neg Neg Neg Neg Neg 512 1448 2048 ≥2896 >2048 >2048
VD42 Neg Neg Neg Neg Neg Neg 724 >2048 ≥2896 ≥2896 >2048 >2048
VD43 Neg Neg Neg Neg Neg Neg 256 2048 1448 ≥2896 2048 1148
VD46 Neg Neg Neg Neg Neg 1448 Neg Neg 90 ≥2896 >2048
VD47 Neg Neg Neg Neg Neg Neg Neg Neg Neg 1024 >2048 >2048
VD50 Neg Neg Neg Neg Neg Neg Neg 362 2048 ≥2896
Page 4 of 5Zhang et al. Vet Res  (2015) 46:132 
the inhibition of both the type-1 response and T cell acti-
vation until it is “too late” to arrest the disease process, 
resulting in incomplete clearance of clearing the virus, 
leading to the persistence. Of course, extrapolation of the 
results from this study on cattle is always questionable 
because persistence with FMD virus also occurs in small 
ruminants [1]. Furthermore, the elevation of serum IL-10 
levels raises the question of why IL-10 induction did not 
occur in all infected cattle and whether IL-10 is the only 
member of this cytokine family that could influence the 
outcome of infection with FMD virus. The apparent rela-
tionship between the development of the carrier state 
and IL-10 response prompts further investigation.
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